These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30636985)

  • 1. Sensitive quantification of BB-22 and its metabolite BB-22 3-carboxyindole, and characterization of new metabolites in authentic urine and/or serum specimens obtained from three individuals by LC-QTRAP-MS/MS and high-resolution LC-Orbitrap-MS/MS.
    Minakata K; Hasegawa K; Nozawa H; Yamagishi I; Saitoh T; Yoshino A; Suzuki M; Kitamoto T; Suzuki O; Watanabe K
    Forensic Toxicol; 2019; 37(1):164-173. PubMed ID: 30636985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection.
    Carlier J; Diao X; Huestis MA
    J Pharm Biomed Anal; 2018 Aug; 157():27-35. PubMed ID: 29754040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of Major Metabolites of AB-FUBINACA in Solid Tissues Obtained from an Abuser.
    Minakata K; Hasegawa K; Nozawa H; Yamagishi I; Suzuki M; Kitamoto T; Suzuki O; Watanabe K
    J Anal Toxicol; 2021 Jul; 45(6):555-565. PubMed ID: 32886766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening, quantification, and confirmation of synthetic cannabinoid metabolites in urine by UHPLC-QTOF-MS.
    Gundersen POM; Spigset O; Josefsson M
    Drug Test Anal; 2019 Jan; 11(1):51-67. PubMed ID: 29996011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and tentative identification of new flunitrazepam metabolites in authentic human urine specimens using liquid chromatography-Q exactive-HF hybrid quadrupole-Orbitrap-mass spectrometry (LC-QE-HF-MS).
    Qin S; Xin G; Wang Y; Qiao J; Zhang W; Xu D; Xu Z; Liu Y; Zhang Y; Lu J
    J Mass Spectrom; 2019 Aug; 54(8):704-715. PubMed ID: 31233253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term stability of 24 synthetic cannabinoid metabolites spiked into whole blood and urine for up to 168 days, and the comparable study for the 6 metabolites in non-spiked real case specimens stored for  1-5 years.
    Minakata K; Hasegawa K; Nozawa H; Yamagishi I; Miyoshi N; Suzuki M; Kitamoto T; Kondo M; Watanabe K; Suzuki O
    Forensic Toxicol; 2022 Jul; 40(2):289-301. PubMed ID: 36454405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Metabolites of AB-PINACA in Solid Tissues Obtained from Its Abuser: Comparison with In Vitro Experiment.
    Minakata K; Hasegawa K; Yamagishi I; Nozawa H; Suzuki M; Kitamoto T; Suzuki O; Watanabe K
    J Anal Toxicol; 2021 Jan; 44(9):1027-1035. PubMed ID: 32232365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens.
    Castaneto MS; Scheidweiler KB; Gandhi A; Wohlfarth A; Klette KL; Martin TM; Huestis MA
    Drug Test Anal; 2015 Jun; 7(6):483-93. PubMed ID: 25231213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing.
    Beuck S; Möller I; Thomas A; Klose A; Schlörer N; Schänzer W; Thevis M
    Anal Bioanal Chem; 2011 Aug; 401(2):493-505. PubMed ID: 21455647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and quantification of predominant metabolites of synthetic cannabinoid MAB-CHMINACA in an authentic human urine specimen.
    Hasegawa K; Minakata K; Gonmori K; Nozawa H; Yamagishi I; Watanabe K; Suzuki O
    Drug Test Anal; 2018 Feb; 10(2):365-371. PubMed ID: 28560823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
    Franz F; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201).
    Diao X; Carlier J; Zhu M; Pang S; Kronstrand R; Scheidweiler KB; Huestis MA
    Forensic Toxicol; 2017 Jan; 35(1):20-32. PubMed ID: 28286577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo detection of the new psychoactive substance AM-694 and its metabolites.
    Bertol E; Vaiano F; Di Milia MG; Mari F
    Forensic Sci Int; 2015 Nov; 256():21-7. PubMed ID: 26295909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens.
    Wohlfarth A; Scheidweiler KB; Castaneto M; Gandhi AS; Desrosiers NA; Klette KL; Martin TM; Huestis MA
    Clin Chem Lab Med; 2015 Feb; 53(3):423-34. PubMed ID: 25263309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and application of a High-Resolution mass spectrometry method for the detection of fentanyl analogs in urine and serum.
    Zhang Y; Halifax JC; Tangsombatvisit C; Yun C; Pang S; Hooshfar S; Wu AHB; Lynch KL
    J Mass Spectrom Adv Clin Lab; 2022 Nov; 26():1-6. PubMed ID: 36065325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC-MS-MS vs ELISA: Validation of a Comprehensive Urine Toxicology Screen by LC-MS-MS and a Comparison of 100 Forensic Specimens.
    Kahl KW; Seither JZ; Reidy LJ
    J Anal Toxicol; 2019 Oct; 43(9):734-745. PubMed ID: 31424082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Power of Orbitrap-based LC-high resolution-MS/MS for comprehensive drug testing in urine with or without conjugate cleavage or using dried urine spots after on-spot cleavage in comparison to established LC-MS
    Michely JA; Meyer MR; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):158-163. PubMed ID: 28755512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine.
    Staeheli SN; Veloso VP; Bovens M; Bissig C; Kraemer T; Poetzsch M
    Drug Test Anal; 2019 Sep; 11(9):1369-1376. PubMed ID: 31219237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
    Hutter M; Broecker S; Kneisel S; Franz F; Brandt SD; Auwarter V
    Curr Pharm Biotechnol; 2018; 19(2):144-162. PubMed ID: 29745330
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.